Testing effectiveness (Phase 2)WithdrawnNCT05180422
What this trial is testing
A Phase I/II Study of AMG 510 in Combination With MVASI in Patients With Advanced, Unresectable or Metastatic KRAS G12C Mutant NSCLC With Asymptomatic Brain Metastasis
Who this might be right for
Non Small Cell Lung Cancer
Criterium, Inc.